Zhonghua Zhong Liu Za Zhi. 2022 Dec 23;44(12):1330-1343. doi: 10.3760/cma.j.cn112152-20220628-00458.
Cancer is a public health and social problem to which great attention should be attached. Not only are there a large number of cancer patients in China, but great differences also exist in etiology, epidemiology, disease spectrum, and treatment between China and western countries. Therefore, tumor-related data in China has its own characteristics. Full reference to the data of western countries cannot accurately reflect the real situation of cancer prevention and treatment in China. If we can integrate, process and analyze Chinese data, and find rules in specific etiology, incidence, drug sensitivity and prognosis, it will play an important role in the formulation of health policy, medical research and disease prevention. The Society of Cancer Big Data and Real World Study of China Anti-Cancer Association organized multidisciplinary experts, combined with domestic and foreign literature and clinical practice, after repeated discussion and revision, finished this consensus including background, analysis and management, direction planning and operation flow, basic design, quality control standards, evidence level classification, data security and privacy standards of big data and real world study. The aim is to take full advantages of Chinese cancer big data to carry out high-quality real world study, and better promote the prevention and treatment of cancer in China.
癌症是一个应予以高度重视的公共卫生和社会问题。中国不仅有大量癌症患者，而且在病因、流行病学、疾病谱以及中国与西方国家的治疗方法等方面也存在很大差异。因此，中国的肿瘤相关数据有其自身特点。完全参照西方国家的数据并不能准确反映中国癌症防治的实际情况。如果我们能够整合、处理和分析中国的数据，并在特定病因、发病率、药物敏感性和预后方面找到规律，这将对卫生政策的制定、医学研究和疾病预防起到重要作用。中国抗癌协会癌症大数据与真实世界研究专业委员会组织多学科专家，结合国内外文献和临床实践，经过反复讨论和修订，完成了本共识，内容包括背景、分析与管理、方向规划与操作流程、基础设计、质量控制标准、证据水平分级、大数据与真实世界研究的数据安全和隐私标准等。目的是充分利用中国癌症大数据开展高质量的真实世界研究，更好地推动中国癌症的防治工作。
